Our in silico findings suggest that the potential anti-obesity and hypolipidemic activities of Cynarae extract, Crataegi extract, and Rosmarini extract could be partly supported by the inhibition of the hepatic CA5A by rosmarinic acid and chlorogenic acid. This evidence concerns the gene CA5A and obesity disorder.